The shareholders of OxyHeal Health Group, the world's leading provider of hyperbaric medicine solutions, sought to sell the 44-year old company. Previous investment banking teams over three attempts were unsuccessful. Keystone was retained and thoroughly understood the company's operations. They developed an aggressive marketing strategy and secured a letter of intent from a strategic buyer. Due diligence delays and restructured terms posed challenges but Keystone worked tirelessly to keep the deal alive. Through creativity and advocacy, Keystone successfully closed the transaction, achieving an unprecedented outcome for shareholders.